Watch the “What This Means" segment here HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin”…
Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old…
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company…
Unveiled at BIO 2025 in Boston, the project marks a major step toward Saudi Arabia's goal to become a global…
University of Louisville researchers use Vivalink's wearable technologies and data platform to measure how urban green spaces impact physical and…
LOUVAIN-LA-NEUVE, Belgium, June 17, 2025 /PRNewswire/ -- One2Treat SA, a fast-growing tech company incorporating the patient voice in all strategic decisions…
Agreement provides Ratio access to Nusano-produced radioisotopes for oncology diagnostics and therapeuticsAccelerates Ratio's clinical pipeline with copper-64 for PET imaging and…
Calgary, Alberta--(Newsfile Corp. - June 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…
REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical…
Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3…